Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms

Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostic microbiology and infectious disease 2019-11, Vol.95 (3), p.114860-114860, Article 114860
Hauptverfasser: de Menezes, Ramon R.P.P.B., Sampaio, Tiago L., Lima, Danya B., Sousa, Paloma L., de Azevedo, Isabella E.P., Magalhães, Emanuel P., Tessarolo, Louise D., Marinho, Márcia Machado, dos Santos, Ricardo Pires, Martins, Alice M.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 114860
container_issue 3
container_start_page 114860
container_title Diagnostic microbiology and infectious disease
container_volume 95
creator de Menezes, Ramon R.P.P.B.
Sampaio, Tiago L.
Lima, Danya B.
Sousa, Paloma L.
de Azevedo, Isabella E.P.
Magalhães, Emanuel P.
Tessarolo, Louise D.
Marinho, Márcia Machado
dos Santos, Ricardo Pires
Martins, Alice M.C.
description Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition. [Display omitted] •(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.
doi_str_mv 10.1016/j.diagmicrobio.2019.06.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2266336197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889319306443</els_id><sourcerecordid>2266336197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</originalsourceid><addsrcrecordid>eNqNkD1OxDAQRi0EgmXhCsiigiJhbGfthA7xLyFRAAWV5Tg28iqJFzuLBCeg5iZchENwEox2QZRUU3zvm9E8hHYJ5AQIP5jmjVMPndPB187nFEiVA8-B0BU0IqWoMgABq2gEgtGsLCu2gTZjnEIiqgLW0QYjbMKA8xG6OeoHN1NBRTc4jY21Rg_YW7z3-fq2n328Z7WLqvatb7F6UK6PA74NzzPV--g7hXWYvzh8j-MQUoitD13cQmtWtdFsL-cY3Z2d3h5fZFfX55fHR1eZLhgdMgGmsZxoqCd1JYS1pa2LQmhmGzERiteiaixQUyiqDS-IaMoJtylhoGlJGBujvcXeWfCPcxMH2bmoTduq3vh5lJRyzhgnlUjo4QJNzmIMxspZcJ0Kz5KA_JYqp_KvVPktVQKXSVkq7yzvzOvONL_VH4sJOFkAJn375EyQUTvTa9O4kHTKxrv_3PkCcyCRFw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2266336197</pqid></control><display><type>article</type><title>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>de Menezes, Ramon R.P.P.B. ; Sampaio, Tiago L. ; Lima, Danya B. ; Sousa, Paloma L. ; de Azevedo, Isabella E.P. ; Magalhães, Emanuel P. ; Tessarolo, Louise D. ; Marinho, Márcia Machado ; dos Santos, Ricardo Pires ; Martins, Alice M.C.</creator><creatorcontrib>de Menezes, Ramon R.P.P.B. ; Sampaio, Tiago L. ; Lima, Danya B. ; Sousa, Paloma L. ; de Azevedo, Isabella E.P. ; Magalhães, Emanuel P. ; Tessarolo, Louise D. ; Marinho, Márcia Machado ; dos Santos, Ricardo Pires ; Martins, Alice M.C.</creatorcontrib><description>Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition. [Display omitted] •(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/j.diagmicrobio.2019.06.012</identifier><identifier>PMID: 31353066</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; Bisabolol ; Cell Line ; Cell Survival - drug effects ; Chagas Disease - drug therapy ; Chagas Disease - parasitology ; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists &amp; inhibitors ; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism ; Inhibitory Concentration 50 ; Macaca mulatta ; Molecular Docking Simulation ; Molecular Structure ; Monocyclic Sesquiterpenes - chemistry ; Monocyclic Sesquiterpenes - pharmacology ; Oxidative Stress - drug effects ; Trypanocidal Agents - pharmacology ; Trypanosoma cruzi ; Trypanosoma cruzi - drug effects ; Trypanosoma cruzi - physiology</subject><ispartof>Diagnostic microbiology and infectious disease, 2019-11, Vol.95 (3), p.114860-114860, Article 114860</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</citedby><cites>FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diagmicrobio.2019.06.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31353066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Menezes, Ramon R.P.P.B.</creatorcontrib><creatorcontrib>Sampaio, Tiago L.</creatorcontrib><creatorcontrib>Lima, Danya B.</creatorcontrib><creatorcontrib>Sousa, Paloma L.</creatorcontrib><creatorcontrib>de Azevedo, Isabella E.P.</creatorcontrib><creatorcontrib>Magalhães, Emanuel P.</creatorcontrib><creatorcontrib>Tessarolo, Louise D.</creatorcontrib><creatorcontrib>Marinho, Márcia Machado</creatorcontrib><creatorcontrib>dos Santos, Ricardo Pires</creatorcontrib><creatorcontrib>Martins, Alice M.C.</creatorcontrib><title>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition. [Display omitted] •(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Bisabolol</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Chagas Disease - drug therapy</subject><subject>Chagas Disease - parasitology</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists &amp; inhibitors</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism</subject><subject>Inhibitory Concentration 50</subject><subject>Macaca mulatta</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Structure</subject><subject>Monocyclic Sesquiterpenes - chemistry</subject><subject>Monocyclic Sesquiterpenes - pharmacology</subject><subject>Oxidative Stress - drug effects</subject><subject>Trypanocidal Agents - pharmacology</subject><subject>Trypanosoma cruzi</subject><subject>Trypanosoma cruzi - drug effects</subject><subject>Trypanosoma cruzi - physiology</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1OxDAQRi0EgmXhCsiigiJhbGfthA7xLyFRAAWV5Tg28iqJFzuLBCeg5iZchENwEox2QZRUU3zvm9E8hHYJ5AQIP5jmjVMPndPB187nFEiVA8-B0BU0IqWoMgABq2gEgtGsLCu2gTZjnEIiqgLW0QYjbMKA8xG6OeoHN1NBRTc4jY21Rg_YW7z3-fq2n328Z7WLqvatb7F6UK6PA74NzzPV--g7hXWYvzh8j-MQUoitD13cQmtWtdFsL-cY3Z2d3h5fZFfX55fHR1eZLhgdMgGmsZxoqCd1JYS1pa2LQmhmGzERiteiaixQUyiqDS-IaMoJtylhoGlJGBujvcXeWfCPcxMH2bmoTduq3vh5lJRyzhgnlUjo4QJNzmIMxspZcJ0Kz5KA_JYqp_KvVPktVQKXSVkq7yzvzOvONL_VH4sJOFkAJn375EyQUTvTa9O4kHTKxrv_3PkCcyCRFw</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>de Menezes, Ramon R.P.P.B.</creator><creator>Sampaio, Tiago L.</creator><creator>Lima, Danya B.</creator><creator>Sousa, Paloma L.</creator><creator>de Azevedo, Isabella E.P.</creator><creator>Magalhães, Emanuel P.</creator><creator>Tessarolo, Louise D.</creator><creator>Marinho, Márcia Machado</creator><creator>dos Santos, Ricardo Pires</creator><creator>Martins, Alice M.C.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201911</creationdate><title>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</title><author>de Menezes, Ramon R.P.P.B. ; Sampaio, Tiago L. ; Lima, Danya B. ; Sousa, Paloma L. ; de Azevedo, Isabella E.P. ; Magalhães, Emanuel P. ; Tessarolo, Louise D. ; Marinho, Márcia Machado ; dos Santos, Ricardo Pires ; Martins, Alice M.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-70edf61c0b5b977ff8fb447c3fd757a6b79df02e4a2ce6417d856f57a30c28133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Bisabolol</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Chagas Disease - drug therapy</topic><topic>Chagas Disease - parasitology</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists &amp; inhibitors</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism</topic><topic>Inhibitory Concentration 50</topic><topic>Macaca mulatta</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Structure</topic><topic>Monocyclic Sesquiterpenes - chemistry</topic><topic>Monocyclic Sesquiterpenes - pharmacology</topic><topic>Oxidative Stress - drug effects</topic><topic>Trypanocidal Agents - pharmacology</topic><topic>Trypanosoma cruzi</topic><topic>Trypanosoma cruzi - drug effects</topic><topic>Trypanosoma cruzi - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Menezes, Ramon R.P.P.B.</creatorcontrib><creatorcontrib>Sampaio, Tiago L.</creatorcontrib><creatorcontrib>Lima, Danya B.</creatorcontrib><creatorcontrib>Sousa, Paloma L.</creatorcontrib><creatorcontrib>de Azevedo, Isabella E.P.</creatorcontrib><creatorcontrib>Magalhães, Emanuel P.</creatorcontrib><creatorcontrib>Tessarolo, Louise D.</creatorcontrib><creatorcontrib>Marinho, Márcia Machado</creatorcontrib><creatorcontrib>dos Santos, Ricardo Pires</creatorcontrib><creatorcontrib>Martins, Alice M.C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Menezes, Ramon R.P.P.B.</au><au>Sampaio, Tiago L.</au><au>Lima, Danya B.</au><au>Sousa, Paloma L.</au><au>de Azevedo, Isabella E.P.</au><au>Magalhães, Emanuel P.</au><au>Tessarolo, Louise D.</au><au>Marinho, Márcia Machado</au><au>dos Santos, Ricardo Pires</au><au>Martins, Alice M.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>2019-11</date><risdate>2019</risdate><volume>95</volume><issue>3</issue><spage>114860</spage><epage>114860</epage><pages>114860-114860</pages><artnum>114860</artnum><issn>0732-8893</issn><eissn>1879-0070</eissn><abstract>Chagas disease is caused by Trypanosoma cruzi and affects about 7 million people worldwide. Benznidazole and nifurtimox have low efficacy and high toxicity. The present study was designed to identify the trypanocidal effect of (−)-α-Bisabolol (BIS) and investigate its mechanism. Epimastigotes and trypomastigotes were cultured with BIS and the viable cells were counted. BIS antiamastigote effect was evaluated using infected LLC-MK2 cells. MTT assay was performed to evaluate BIS cytotoxicity. Growth recovery was assessed to evaluate BIS effect after short times of exposure. BIS mechanism was investigated through flow cytometry, with 7-AAD and Annexin V-PE. DCFH-DA, rhodamine 123 (Rho123) and acridine orange (AO). Finally, enzymatic and computational assays were performed to identify BIS interaction with T. cruzi GAPDH (tcGAPDH). BIS showed an inhibitory effect on epimastigotes after all tested periods, as well on trypomastigotes. It caused cytotoxicity on LLC-MK2 cells at higher concentrations, with selectivity index (SeI) = 26.5. After treatment, infected cells showed a decrease in infected cells, the number of amastigotes per infected cell and the survival index (SuI). Growth recovery demonstrated that BIS effect causes rapid death of T. cruzi. Flow cytometry showed that BIS biological effect is associated with apoptosis induction, increase in cytoplasmic ROS and mitochondrial transmembrane potential, while reservosome swelling was observed at a late stage. Also, BIS action mechanism may be associated to tcGAPDH inhibition. Altogether, the results demonstrate that BIS causes cell death in Trypanosoma cruzi Y strain forms, with the involvement of apoptosis and oxidative stress and enzymatic inhibition. [Display omitted] •(−)-α-Bisabolol (BIS) presents trypanocidal effect against epimastigotes, trypomastigotes and amastigotes from Trypanosoma cruzi strain Y.•BIS induces cell death on T. cruzi with apoptosis, cytoplasmic oxidative stress, mitochondrial depolarization and reservosome swelling.•BIS causes inhibition of tcGAPDH, which can be related to its mechanism on T. cruzi cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31353066</pmid><doi>10.1016/j.diagmicrobio.2019.06.012</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0732-8893
ispartof Diagnostic microbiology and infectious disease, 2019-11, Vol.95 (3), p.114860-114860, Article 114860
issn 0732-8893
1879-0070
language eng
recordid cdi_proquest_miscellaneous_2266336197
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Apoptosis
Apoptosis - drug effects
Bisabolol
Cell Line
Cell Survival - drug effects
Chagas Disease - drug therapy
Chagas Disease - parasitology
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - antagonists & inhibitors
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) - metabolism
Inhibitory Concentration 50
Macaca mulatta
Molecular Docking Simulation
Molecular Structure
Monocyclic Sesquiterpenes - chemistry
Monocyclic Sesquiterpenes - pharmacology
Oxidative Stress - drug effects
Trypanocidal Agents - pharmacology
Trypanosoma cruzi
Trypanosoma cruzi - drug effects
Trypanosoma cruzi - physiology
title Antiparasitic effect of (−)-α-bisabolol against Trypanosoma cruzi Y strain forms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A54%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiparasitic%20effect%20of%20(%E2%88%92)-%CE%B1-bisabolol%20against%20Trypanosoma%20cruzi%20Y%20strain%20forms&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=de%20Menezes,%20Ramon%20R.P.P.B.&rft.date=2019-11&rft.volume=95&rft.issue=3&rft.spage=114860&rft.epage=114860&rft.pages=114860-114860&rft.artnum=114860&rft.issn=0732-8893&rft.eissn=1879-0070&rft_id=info:doi/10.1016/j.diagmicrobio.2019.06.012&rft_dat=%3Cproquest_cross%3E2266336197%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2266336197&rft_id=info:pmid/31353066&rft_els_id=S0732889319306443&rfr_iscdi=true